Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Pfizer CDR CAD Hedged | NEO:PFE | NEO | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.02 | -0.17% | 11.58 | 11.56 | 11.58 | 11.60 | 11.51 | 11.57 | 18,018 | 16:52:04 |
From Nov 2019 to Nov 2024
DOW JONES NEWSWIRES
Standard & Poor's said online travel agent Priceline.com Inc. (PCLN) will replace Schering-Plough Corp. (SGP) in the S&P 500 index once that pharmaceutical company is being acquired by rival Merck & Co. Inc. (MRK).
Standard & Poor's didn't disclose when the changes would occur, as Schering-Plough's deal with Merck is pending final approval.
Earlier Thursday, the Federal Trade Commission cleared Merck's $41 billion acquisition of Schering-Plough.
The index recently lost another drug maker when Wyeth (WYE) was replaced by thin-film solar panel maker First Solar Inc. (FSLR) because of Wyeth's acquisition by larger rival Pfizer Inc. (PFE).
Priceline shares were up 4.5% to $170 in after-hours trading. The stock has pulled back from its 52-week high hit Monday but remains up nearly quadruple over the past year.
-By Kathy Shwiff, Dow Jones Newswires; 212-416-2357; Kathy.Shwiff@dowjones.com
1 Year Pfizer CDR CAD Hedged Chart |
1 Month Pfizer CDR CAD Hedged Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
